Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04182815 · ClinicalTrials.gov registry record
Transbronchial Biopsy Assisted by Robot Guidance in the Evaluation of Tumors of the Lung
A clinical trial of Lung Cancer and Pulmonary Nodule, sponsored by Auris Health.
- Completed
- Registry status
- 691
- Enrollment target
- 19
- Study locations
NCT04182815 is a study of Lung Cancer and Pulmonary Nodule that has completed, run by Auris Health. The registered enrollment target is 691 participants, below the 934-participant average among 409 other Lung Cancer trials with a reported enrollment target (26% lower). The trial reports 19 study locations across 16 states.
The verdict
NCT04182815, a study of Lung Cancer and Pulmonary Nodule, has completed, sponsored by Auris Health.
- COMPLETED
- Registry status
- 691 participants
- Enrollment target
- 19
- Study locations
Study Summary
This study is designed to evaluate clinical safety and diagnostic accuracy of the robotic-assisted bronchoscopy with biopsy performed with the Monarch™ Endoscopy Platform in a broad range of patients with pulmonary lesions.
Conditions Studied
Interventions
- DEVICE Robotic assisted bronchoscopy
Study Locations (19)
California
- Costal Pulmonary Associates - Encinitas
- Eisenhower Medical Center - Rancho Mirage
Illinois
- University of Chicago Medicine - Chicago
- Northwestern Medicine Central DuPage Hospital - Winfield
Pennsylvania
- Clinical Research Associates of Central PA - Altoona
- University of Pittsburgh Medical Center, Hamot - Erie
Arizona
- Mayo Clinic Arizona - Scottsdale
Connecticut
- The University of Connecticut Health Center - Farmington
Florida
- Sarasota Memorial Hospital - Sarasota
Indiana
- Franciscan Health Indianapolis - Indianapolis
Michigan
- Spectrum Health System - Grand Rapids
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 691 participants |
| Start Date | 2019-12-10 |
| Est. Completion | 2023-12-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04182815
The ClinicalTrials.gov registry entry for NCT04182815 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 691 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 934-participant average among 409 other Lung Cancer trials with a reported enrollment target (26% lower). The listed sponsor is Auris Health, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Robotic assisted bronchoscopy is the first listed.
NCT04182815 reports 19 study locations spanning 16 distinct geographic areas - top geographies include California, Illinois, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04182815 about?
NCT04182815 is a clinical study titled "Transbronchial Biopsy Assisted by Robot Guidance in the Evaluation of Tumors of the Lung". This study is designed to evaluate clinical safety and diagnostic accuracy of the robotic-assisted bronchoscopy with biopsy performed with the Monarch™ Endoscopy Platform in a broad range of patients with pulmonary lesions.
What is the current status of trial NCT04182815?
This trial is currently completed. The enrollment target is 691 participants. The study started on 2019-12-10. Estimated completion is 2023-12-15.
What conditions does trial NCT04182815 study?
This clinical trial studies the following conditions: Lung Cancer, Pulmonary Nodule.
What interventions are being tested in trial NCT04182815?
The interventions under investigation include: Robotic assisted bronchoscopy (DEVICE).
Who is sponsoring clinical trial NCT04182815?
This trial is sponsored by Auris Health, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04182815 being conducted?
This trial has 19 study locations across Arizona, California, Connecticut, Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Health Opportunities and Promoters of Equitable Screening for Lung Cancer
RECRUITING
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.